Cargando…
Combination of convalescent plasma therapy and repurposed drugs to treat severe COVID‐19 patient with multimorbidity
Combination of convalescent plasma therapy and repurposed drugs such as dexamethasone and remdesivir could be beneficial for severe COVID‐19 patients with obesity and chronic diseases such as diabetes and hypertension.
Autores principales: | Das, Santa Kumar, Ranabhat, Kamal, Bhattarai, Suraj, Karki, Khem Bahadur, Gyanwali, Pradip, Paneru, Hem Raj, Nepal, Bipin, Dumre, Shyam Prakash, Acharya, Subhash Prasad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013972/ https://www.ncbi.nlm.nih.gov/pubmed/33821192 http://dx.doi.org/10.1002/ccr3.3964 |
Ejemplares similares
-
Experience of Treating COVID-19 With Remdesivir and Convalescent Plasma in a Resource-Limited Setting: A Prospective, Observational Study
por: Koirala, Janak, et al.
Publicado: (2021) -
Prevalence, pattern and determinants of chronic disease multimorbidity in Nepal: secondary analysis of a national survey
por: Dhungana, Raja Ram, et al.
Publicado: (2021) -
An outbreak investigation of scrub typhus in Nepal: confirmation of local transmission
por: Dhimal, Meghnath, et al.
Publicado: (2021) -
Successful lumbar puncture with Taylor's approach for the diagnostic workup of meningitis in a patient with Ankylosing spondylitis
por: Shrestha, Gentle Sunder, et al.
Publicado: (2015) -
Prevalence and factors associated with joint pain in Nepal: findings from a countrywide cross-sectional STEPS survey
por: Poudyal, Anil, et al.
Publicado: (2021)